Patent Expiry
BFRI: AMELUZ: recorded patent 12280146 expiry
December 8, 2043 · AMINOLEVULINIC ACID HYDROCHLORIDE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 8, 2043
- Company
- Biofrontera Inc. (BFRI)
- Drug
- AMINOLEVULINIC ACID HYDROCHLORIDE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
AMELUZ: recorded patent 12280146 expiry
Orange Book application NDA208081, product 001, listed patent 12280146 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source